{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T02:58:45Z","timestamp":1764212325300},"reference-count":40,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2023,12,25]]},"DOI":"10.1253\/circj.cj-23-0567","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T22:52:19Z","timestamp":1696546339000},"page":"10-19","source":"Crossref","is-referenced-by-count":6,"title":["Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System Inhibitors"],"prefix":"10.1253","volume":"88","author":[{"given":"Ryo","family":"Numazawa","sequence":"first","affiliation":[{"name":"Graduate School of Medicine, Sapporo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Katano","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"},{"name":"Second Division of Physical Therapy, Sapporo Medical University School of Health Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Nagaoka","sequence":"additional","affiliation":[{"name":"Division of Rehabilitation, Sapporo Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Ohori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Cardiology, Hokkaido Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Honma","sequence":"additional","affiliation":[{"name":"Second Division of Physical Therapy, Sapporo Medical University School of Health Science"},{"name":"Department of Rehabilitation, Sapporo Cardiovascular Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Second Division of Physical Therapy, Sapporo Medical University School of Health Science"},{"name":"Department of Rehabilitation, Japanese Red Cross Asahikawa Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Yamano","sequence":"additional","affiliation":[{"name":"Second Division of Physical Therapy, Sapporo Medical University School of Health Science"},{"name":"Department of Rehabilitation, Teine Keijinkai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arata","family":"Osanami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Public Health, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"},{"name":"Department of Health Care Administration and Management, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: A comprehensive and updated review of epidemiology. <i>Cardiovasc Res<\/i> 2023; 118: 3272\u20133287, doi:10.1093\/cvr\/cvac013.","DOI":"10.1093\/cvr\/cvac013"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Kinugawa S, Takada S, Matsushima S, Okita K, Tsutsui H. Skeletal muscle abnormalities in heart failure. <i>Int Heart J<\/i> 2015; 56: 475\u2013484, doi:10.1536\/ihj.15-108.","DOI":"10.1536\/ihj.15-108"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rosenberg IH. Sarcopenia: Origins and clinical relevance. <i>J Nutr<\/i> 1997; 127: S990\u2013S991, doi:10.1093\/jn\/127.5.990s.","DOI":"10.1093\/jn\/127.5.990S"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Shen Y, Chen J, Chen X, Hou L, Lin X, Yang M. Prevalence and associated factors of sarcopenia in nursing home residents: A systematic review and meta-analysis. <i>J Am Med Dir Assoc<\/i> 2019; 20: 5\u201313, doi:10.1016\/j.jamda.2018.09.012.","DOI":"10.1016\/j.jamda.2018.09.012"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Malouf CA, et al. Sarcopenia and cardiovascular diseases. <i>Circulation<\/i> 2023; 147: 1534\u20131553, doi:10.1161\/circulationaha.123.064071.","DOI":"10.1161\/CIRCULATIONAHA.123.064071"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. F\u00fclster S, Tacke M, Sandek A, Ebner N, Tsch\u00f6pe C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: Results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). <i>Eur Heart J<\/i> 2013; 34: 512\u2013519, doi:10.1093\/eurheartj\/ehs381.","DOI":"10.1093\/eurheartj\/ehs381"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ohori K, Yano T, Katano S, Kouzu H, Honma S, Shimomura K, et al. High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: An explanation of the obesity paradox. <i>BMC Geriatr<\/i> 2021; 21: 16, doi:10.1186\/s12877-020-01950-9.","DOI":"10.1186\/s12877-020-01950-9"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Katano S, Honma S, Nagaoka R, Numazawa R, Yamano K, Fujisawa Y, et al. Anthropometric parameters-derived estimation of muscle mass predicts all-cause mortality in heart failure patients. <i>ESC Heart Fail<\/i> 2022, doi:10.1002\/ehf2.14121.","DOI":"10.1002\/ehf2.14121"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Miura S. The renin-angiotensin-aldosterone system: A new look at an old system. <i>Hypertens Res<\/i> 2023; 46: 932\u2013933, doi:10.1038\/s41440-023-01210-4.","DOI":"10.1038\/s41440-023-01210-4"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, et al. JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure. <i>Circ J<\/i> 2021; 85: 2252\u20132291, doi:10.1253\/circj.CJ-21-0431.","DOI":"10.1253\/circj.CJ-21-0431"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Cabello-Verrugio C, Morales MG, Rivera JC, Cabrera D, Simon F. Renin-angiotensin system: An old player with novel functions in skeletal muscle. <i>Med Res Rev<\/i> 2015; 35: 437\u2013463, doi:10.1002\/med.21343.","DOI":"10.1002\/med.21343"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Powers SK, Morton AB, Hyatt H, Hinkley MJ. The renin-angiotensin system and skeletal muscle. <i>Exerc Sport Sci Rev<\/i> 2018; 46: 205\u2013214, doi:10.1249\/jes.0000000000000158.","DOI":"10.1249\/JES.0000000000000158"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Inoue N, Kinugawa S, Suga T, Yokota T, Hirabayashi K, Kuroda S, et al. Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle. <i>Am J Physiol Heart Circ Physiol<\/i> 2012; 302: H1202\u2013H1210, doi:10.1152\/ajpheart.00534.2011.","DOI":"10.1152\/ajpheart.00534.2011"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Yano T, Katano S, Kouzu H, Nagaoka R, Inoue T, Takamura Y, et al. Distinct determinants of muscle wasting in nonobese heart failure patients with and without type 2 diabetes mellitus. <i>J Diabetes<\/i> 2021; 13: 7\u201318, doi:10.1111\/1753-0407.13090.","DOI":"10.1111\/1753-0407.13090"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Driggin E, Cohen LP, Gallagher D, Karmally W, Maddox T, Hummel SL, et al. Nutrition Assessment and Dietary Interventions in Heart Failure JACC Review Topic of the Week. <i>J Am Coll Cardiol<\/i> 2022; 79: 1623\u20131635, doi:10.1016\/j.jacc.2022.02.025.","DOI":"10.1016\/j.jacc.2022.02.025"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Katano S, Yano T, Shimizu M, Ohori K, Kouzu H, Koyama M, et al. Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients? <i>ESC Heart Fail<\/i> 2021; 8: 2617\u20132624, doi:10.1002\/ehf2.13430.","DOI":"10.1002\/ehf2.13430"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Vaduganathan M, Cheema B, Cleveland E, Sankar K, Subacius H, Fonarow GC, et al. Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: The ASTRONAUT trial. <i>Eur J Heart Fail<\/i> 2018; 20: 677\u2013686, doi:10.1002\/ejhf.973.","DOI":"10.1002\/ejhf.973"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kobayashi M, Stienen S, Maaten JM, Dickstein K, Samani NJ, Lang CC, et al. Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure. <i>ESC Heart Fail<\/i> 2020; 7: 953\u2013963, doi:10.1002\/ehf2.12634.","DOI":"10.1002\/ehf2.12634"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H. High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure. <i>Cor Vasa<\/i> 2014; 56: e463\u2013e470, doi:10.1016\/j.crvasa.2014.06.004.","DOI":"10.1016\/j.crvasa.2014.06.004"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. <i>Circ J<\/i> 2019; 83: 2084\u20132184, doi:10.1253\/circj.CJ-19-0342.","DOI":"10.1253\/circj.CJ-19-0342"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Katano S, Yano T, Ohori K, Nagano N, Honma S, Shimomura K, et al. Novel prediction equation for appendicular skeletal muscle mass estimation in patients with heart failure: Potential application in daily clinical practice. <i>Eur J Prev Cardiol<\/i> 2020; 28: e18\u2013e21, doi:10.1177\/2047487320904236.","DOI":"10.1177\/2047487320904236"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on sarcopenia diagnosis and treatment. <i>J Am Med Dir Assoc<\/i> 2020; 21: 300\u2013307.e2, doi:10.1016\/j.jamda.2019.12.012.","DOI":"10.1016\/j.jamda.2019.12.012"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Ishigo T, Katano S, Yano T, Kouzu H, Ohori K, Nakata H, et al. Overestimation of glomerular filtration rate by creatinine-based equation in heart failure patients is predicted by a novel scoring system. <i>Geriatr Gerontol Int<\/i> 2020; 20: 752\u2013758, doi:10.1111\/ggi.13959.","DOI":"10.1111\/ggi.13959"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Austin PC, White IR, Lee DS, van Buuren S. Missing data in clinical research: A tutorial on multiple imputation. <i>Can J Cardiol<\/i> 2021; 37: 1322\u20131331, doi:10.1016\/j.cjca.2020.11.010.","DOI":"10.1016\/j.cjca.2020.11.010"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R, et al. Comparison of propensity score methods and covariate adjustment evaluation in 4 cardiovascular studies. <i>J Am Coll Cardiol<\/i> 2017; 69: 345\u2013357, doi:10.1016\/j.jacc.2016.10.060.","DOI":"10.1016\/j.jacc.2016.10.060"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Pandey A, Kitzman DW, Nelson MB, Pastva AM, Duncan P, Whellan DJ, et al. Frailty and effects of a multidomain physical rehabilitation intervention among older patients hospitalized for acute heart failure. <i>JAMA Cardiol<\/i> 2023; 8: 167\u2013176, doi:10.1001\/jamacardio.2022.4903.","DOI":"10.1001\/jamacardio.2022.4903"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Chadwick JA, Hauck JS, Lowe J, Shaw JJ, Guttridge DC, Gomez-Sanchez CE, et al. Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target. <i>FASEB J<\/i> 2015; 29: 4544\u20134554, doi:10.1096\/fj.15-276782.","DOI":"10.1096\/fj.15-276782"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Funder JW. Mineralocorticoid receptors: Distribution and activation. <i>Heart Fail Rev<\/i> 2005; 10: 15\u201322, doi:10.1007\/s10741-005-2344-2.","DOI":"10.1007\/s10741-005-2344-2"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Fuller PJ, Young MJ. Mechanisms of mineralocorticoid action. <i>Hypertension<\/i> 2005; 46: 1227\u20131235, doi:10.1161\/01.hyp.0000193502.77417.17.","DOI":"10.1161\/01.HYP.0000193502.77417.17"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hauck JS, Lowe J, Rastogi N, McElhanon KE, Petrosino JM, Peczkowski KK, et al. Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy. <i>Hum Mol Genet<\/i> 2019; 28: 2030\u20132045, doi:10.1093\/hmg\/ddz039.","DOI":"10.1093\/hmg\/ddz039"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Hauck JS, Howard ZM, Lowe J, Rastogi N, Pico MG, Swager SA, et al. Mineralocorticoid receptor signaling contributes to normal muscle repair after acute injury. <i>Front Physiol<\/i> 2019; 10: 1324, doi:10.3389\/fphys.2019.01324.","DOI":"10.3389\/fphys.2019.01324"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Basualto-Alarc\u00f3n C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and androgens: A link between pathology and treatment. <i>Front Endocrinol<\/i> 2014; 5: 217, doi:10.3389\/fendo.2014.00217.","DOI":"10.3389\/fendo.2014.00217"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Santos MRD, Storer TW. Testosterone treatment as a function-promoting therapy in sarcopenia associated with aging and chronic disease. <i>Endocrinol Metab Clin North Am<\/i> 2022; 51: 187\u2013204, doi:10.1016\/j.ecl.2021.11.012.","DOI":"10.1016\/j.ecl.2021.11.012"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Ishikawa T, Morimoto S, Ichihara A. Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism. <i>Hypertens Res<\/i> 2022; 45: 496\u2013506, doi:10.1038\/s41440-021-00836-6.","DOI":"10.1038\/s41440-021-00836-6"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Karagiannis A, Tziomalos K, Kakafika A, Florentin M, Athyros VG. Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism. <i>Nephrol Dial Transplant<\/i> 2007; 22: 293\u2013293, doi:10.1093\/ndt\/gfl500.","DOI":"10.1093\/ndt\/gfl500"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, et al. Spironolactone for heart failure with preserved ejection fraction. <i>N Engl J Med<\/i> 2014; 370: 1383\u20131392, doi:10.1056\/nejmoa1313731.","DOI":"10.1056\/NEJMoa1313731"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Ishikawa S, Naito S, Iimori S, Takahashi D, Zeniya M, Sato H, et al. Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease. <i>PLoS One<\/i> 2018; 13: e0192990, doi:10.1371\/journal.pone.0192990.","DOI":"10.1371\/journal.pone.0192990"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Hanai T, Shiraki M, Miwa T, Watanabe S, Imai K, Suetsugu A, et al. Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis. <i>Hepatol Res<\/i> 2019; 49: 82\u201395, doi:10.1111\/hepr.13244.","DOI":"10.1111\/hepr.13244"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Nakano I, Tsuda M, Kinugawa S, Fukushima A, Kakutani N, Takada S, et al. Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure. <i>J Cardiol<\/i> 2020; 76: 109\u2013114, doi:10.1016\/j.jjcc.2020.01.003.","DOI":"10.1016\/j.jjcc.2020.01.003"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Sargeant JA, Henson J, King JA, Yates T, Khunti K, Davies MJ. A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans. <i>Endocrinol Metab<\/i> 2019; 34: 247\u2013262, doi:10.3803\/enm.2019.34.3.247.","DOI":"10.3803\/EnM.2019.34.3.247"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/88\/1\/88_CJ-23-0567\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:49:51Z","timestamp":1715575791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/88\/1\/88_CJ-23-0567\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-23-0567","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]},"article-number":"CJ-23-0567"}}